Solid Biosciences Reports Additional Preclinical Data Demonstrating that its Novel Capsid, AAV-SLB101, Provides Superior Transduction Efficiency and Enhanced Distribution to Skeletal MuscleGlobeNewsWire • 10/17/22
Solid Biosciences Presents New SGT-001 IGNITE DMD Study Results at World Muscle Society 2022 Congress Demonstrating Improvements in Ambulatory FunctionGlobeNewsWire • 10/13/22
SLDB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Solid Biosciences Inc. Is Fair to ShareholdersBusiness Wire • 09/30/22
Solid Biosciences Announces Acquisition of AavantiBio and Concurrent $75 Million Private PlacementGlobeNewsWire • 09/30/22
Solid Biosciences Inc. (SLDB) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/11/22
Solid Biosciences Provides Second Quarter 2022 Business Update and Financial ResultsGlobeNewsWire • 08/11/22
Solid Biosciences Reports Inducement Grant to New Senior Vice President, QualityGlobeNewsWire • 06/02/22
Solid Biosciences Inc. (SLDB) CEO Ilan Ganot on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/30/22
Solid Biosciences Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular DystrophyGlobeNewsWire • 04/27/22
Solid Biosciences Posts Two-Year Efficacy, Safety Data From Duchenne Gene Therapy TrialBenzinga • 03/14/22
Solid Biosciences Inc. (SLDB) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/14/22
Solid Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and 2-Year Efficacy and Safety Data from the Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001GlobeNewsWire • 03/14/22
Solid Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare ConferenceGlobeNewsWire • 02/10/22
Solid Biosciences to Present at 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/06/22
All You Need to Know About Solid Biosciences Inc. (SLDB) Rating Upgrade to BuyZacks Investment Research • 01/05/22
Solid Biosciences Inc. (SLDB) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/03/21
Solid Biosciences Provides Third Quarter 2021 Business Update and Financial ResultsGlobeNewsWire • 11/03/21
Pathway Development Consortium Releases Draft White Paper to Facilitate AAV Gene Therapy DevelopmentGlobeNewsWire • 11/02/21
Solid Biosciences to Participate at the Jefferies Gene Therapy/Editing SummitGlobeNewsWire • 10/21/21
Solid Biosciences and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing PartnershipBusiness Wire • 10/04/21
Solid Biosciences Reports Additional Pulmonary Function Results from the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001GlobeNewsWire • 09/29/21